title: [Clinical use of a GnRH analogue in a depot preparation (leuprolide acetate) in patients with surgical indication for uterine fibromyoma].
abstract: During 1992 and 1993, twenty-eight women with uterine leiomyomata received GnRH-agonist (leuprolide acetate) for 3 months before hysterectomy or myomectomy. The decrease in uterine volume and secondary anemia with its collateral effects were assessed, then surgical and post-surgical advantages were assessed too. The real advantages of this treatment are studied and distinguished from theoretic advantages.
authors.affiliation: I Clinica Ostetrica e Ginecologica, Università degli Studi di Catania.
authors.forename: G
authors.initials: G
authors.lastname: Mignemi
authors.forename: A
authors.initials: A
authors.lastname: Garozzo
authors.forename: A
authors.initials: A
authors.lastname: Livatino
authors.forename: L
authors.initials: L
authors.lastname: Di Leo
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007889:Leiomyoma / Q000601:surgery*; D016729:Leuprolide / Q000008:administration & dosage*; D011292:Premedication; D014594:Uterine Neoplasms / Q000601:surgery*
chemical_list: D016729:Leuprolide
vernacular_title: Impiego clinico di un analogo GnRH in preparazione depot (leuprolide acetato) nelle pazienti affette da fibromiomi uterini con indicazione chirurgica.